Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-10-01
1988-05-10
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544319, 544301, 544311, A61K 31505, C07D23946, C07D23934, C07D23928
Patent
active
047436050
ABSTRACT:
Certain substituted amides of saturated fatty acids are potent inhibitors of the enzyme acyl-CoA:cholesterol acyltransferase and are thus useful agents for inhibiting the intestinal absorption of cholesterol.
REFERENCES:
patent: 4250178 (1981-02-01), Bucher et al.
patent: 4410697 (1983-10-01), Torok et al.
Chem. Abstracts, vol. 76, No. 3, 14463j.
Chem. Abstracts, Volkenshtein et al., vol. 104, 199590m, (1986).
Chem. Abstracts, Boyes et al., vol. 94, 121134w, (1981).
Hoefle Milton L.
Holmes Ann
Roth Bruce D.
Janssen Jerry F.
Richter J.
Rotman Alan L.
Warner-Lambert & Company
LandOfFree
Saturated fatty acid amides as inhibitors of acyl-coa:cholestero does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Saturated fatty acid amides as inhibitors of acyl-coa:cholestero, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Saturated fatty acid amides as inhibitors of acyl-coa:cholestero will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1321212